Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Simultaneous or Sequential Combination of Physical and Cognitive Training

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03614182
Recruitment Status : Completed
First Posted : August 3, 2018
Last Update Posted : July 28, 2021
Sponsor:
Information provided by (Responsible Party):
Li-Ling Chuang, Chang Gung University

Brief Summary:
The objective of this study is to investigate psychometric properties of dual-task walking assessments and compare effects of simultaneous or sequential combination of physical and cognitive training on dual-task walking and cognitive performance for community-dwelling healthy older adults.

Condition or disease Intervention/treatment Phase
Healthy Older Adults Device: physical training concurrent with cognitive training Device: physical training followed by cognitive training Device: physical training without cognitive training Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 70 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Effects of Simultaneous or Sequential Combination of Physical and Cognitive Training on Dual-task Walking Performance for Community-dwelling Healthy Older Adults: a Randomized Controlled Trial.
Actual Study Start Date : August 6, 2018
Actual Primary Completion Date : May 31, 2021
Actual Study Completion Date : May 31, 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Health Checkup

Arm Intervention/treatment
Experimental: physical training concurrent with cognitive training
The physical training concurrent with cognitive training group (the P+C group) will receive training at progressively increasing task difficulty 3 times a week for 12 weeks and followed by another 12 weeks without exercise (follow-up).
Device: physical training concurrent with cognitive training
The P+C group will undertake standing balance, stepping, and treadmill walking training while concurrently perform cognitive tasks.
Other Name: P+C

Active Comparator: physical training followed by cognitive training
The physical training followed by cognitive training will receive training at progressively increasing task difficulty 3 times a week for 12 weeks and followed by another 12 weeks without exercise (follow-up).
Device: physical training followed by cognitive training
The P-then-C group will train the same set of standing balance, stepping, and treadmill walking activities as the P+C group while followed by cognitive training later.
Other Name: P-then-C

Active Comparator: physical training without cognitive training
The physical training without cognitive training group will receive training at progressively increasing task difficulty 3 times a week for 12 weeks and followed by another 12 weeks without exercise (follow-up).
Device: physical training without cognitive training
The P group will only train the same set of standing balance, stepping, and treadmill walking activities as the other two groups.
Other Name: P




Primary Outcome Measures :
  1. gait speed [ Time Frame: 5 minutes ]
    Participants will walk 10m at their preferred speed and at fast speed. A 12-meter walkway will be used for walking testing. In order to allow the subjects to have enough distance to accelerate and decelerate, only the time taken to walk the middle 10 meters will be recorded by a stopwatch. The primary gait parameter is gait speed (cm/s) under dual-task walking conditions using the 10 Meter Walking Test,

  2. composite score [ Time Frame: 10 minutes ]
    A composite score for cognitive-task performance will be calculated by dividing the accuracy (% correct responses) with the reaction time of correct answers (milliseconds), which accounts for speed-accuracy trade-offs in the overall dual-task effect.


Secondary Outcome Measures :
  1. Berg Balance Scale (BBS). [ Time Frame: 5-10 minutes ]
    The BBS is a 14-item scale quantitatively assesses both static and dynamic balance. The items are scored from 0 to 4, with a score of 0 representing independent item completion. Scores of the BBS range from 0 to 56, with higher scores suggest better balance.

  2. Mini-Balance Evaluation Systems Test (Mini-BESTest). [ Time Frame: 10 minutes ]
    The Mini-BESTest consists of 14 items and includes four subscales: anticipatory postural adjustments, reactive postural control, sensory orientation, and dynamic gait. Each item is rated on a three-point ordinal scale (0 = severe, 1=moderate, and 2 = normal), with a maximum score of 28 points.

  3. Timed Up and Go Test (TUG). [ Time Frame: 2 minutes ]
    The TUG test will be used as an index of dynamic balance of the elderly. At the signal, participants stand up, walk 3m, turn, walk back, and sit down again. The score is the time to complete the test measured using a stopwatch. The TUG test will be administered under the single-task (preferred speed and maximum fast) and dual-task conditions (tray carrying and counting backward by 3s). In dual-task condition, participants will be asked to perform the TUG test while carrying a tray with glasses (dual-TUG manual) or counting backward by 3s (dual-TUG cognition). The instruction for dual-TUG tests is to walk with your comfortable speed and concurrently perform a secondary task (carry the tray in front of you with both hands without dropping glasses on the tray or counting backward by 3s).

  4. Functional Gait Assessment (FGA). [ Time Frame: 10 minutes ]
    The FGA is comprised of 10-item that contains 7 of 8 items (except walking around obstacles) from the Dynamic Gait Index and 3 additional tasks, including walking with a narrow base of support, walking with the eyes closed, and walking backward. Subjects' performance of each test item was rated on a 4-point scale (0-3), with the total score ranging between 0 and 30.

  5. Physical Activity Scale for the Elderly (PASE). [ Time Frame: 5 minutes ]
    The Chinese version of the PASE (PASE-C) will with good test-retest reliability and concurrent validity be used to quantify activity levels for the elderly

  6. Chair Stand Test (CS) [ Time Frame: 2 minutes ]
    The Chair Stand Test measures lower extremity muscular strength. The participants will be instructed to stand from a seated on the chair position as much as possible for 30 seconds. The total number of stands was counted in 30 seconds. Timed five-chair stand (TCS) is the time measured using a stopwatch to complete five times of standing from sitting.

  7. Muscle Strength of Lower-Extremity [ Time Frame: 10 minutes ]
    Handheld dynamometers (MicroFET2, Hoggan Health Industries Inc, West Jordan, Utah; Jamar ® Plus+ hand dynamometer, Patterson Medical® Sammons Preston®) will be used to measure the maximum isometric strength of tibialis anterior and grip Handheld dynamometers (MicroFET2, Hoggan Health Industries Inc, West Jordan, Utah; Jamar ® Plus+ hand dynamometer, Patterson Medical® Sammons Preston®) will be used to measure the maximum isometric strength of tibialis anterior and grip strength (averaged over three attempts and left and right limbs) using a standard protocol with high test-retest reliability.

  8. Activity-specific Balance Confidence Scale (ABC). [ Time Frame: 2 minutes ]
    The ABC will be used to determine fear of falling and self-reported confidence when performing 15 different daily activities, such as walking around the house, walking up and down stairs, and walking on slippery floors. A confidence rating scale ranges from 0% to 100%, with 0% indicating no confidence, and 100% indicating full confidence.

  9. Geriatric Depression Scale Short Form (GDS-SF). [ Time Frame: 2 minutes ]
    Previous studies showed that physical activity is negatively associated with mental disorder, such as depressive symptoms in older adults. Depressive symptoms will be assessed using the 15-item GDS-SF rating from 0 to 15.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   65 Years and older   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • age more than 65 years old
  • able to walk 10 m;
  • no severe vision, hearing, cognition, and language problems.

Exclusion Criteria:

  • neurological or musculoskeletal diagnosis that affects walking
  • unable standing for at least 2 minutes,
  • MMSE score <24 or severe uncorrected visual deficits
  • moderate to severe high blood pressure (systolic pressure ≧ 160mmHg and diastolic blood pressure ≧ 100mmHg )

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03614182


Locations
Layout table for location information
Taiwan
Chang Gung University
Taoyuan, Taiwan, 333
Sponsors and Collaborators
Chang Gung University
Layout table for additonal information
Responsible Party: Li-Ling Chuang, Associated Professor, Chang Gung University
ClinicalTrials.gov Identifier: NCT03614182    
Other Study ID Numbers: 201702091B0
First Posted: August 3, 2018    Key Record Dates
Last Update Posted: July 28, 2021
Last Verified: July 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No